About this study
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
Study locations
Canada
Alberta
Calgary (1)
- Alberta Children's Hospital — Recruiting
British Columbia
Vancouver (1)
- BC Children's Hospital — Recruiting
Ontario
Ottawa (1)
- Children's Hospital of Eastern Ontario — Recruiting
United States
California
Los Angeles (1)
- Cedars-Sinai Guerin Children's — Not Yet Recruiting
San Diego (1)
- Rady Children's Hospital, San Diego — Recruiting
Colorado
Aurora (1)
- Children's Hospital Colorado, Anschutz Medical Campus — Recruiting
Georgia
Atlanta (1)
- Emory University School of Medicine — Recruiting
Illinois
Chicago (1)
- Rush University Children's Hospital — Recruiting
Massachusetts
Boston (1)
- Boston Children's Hospital — Recruiting
North Carolina
Carrboro (1)
- The Carolina Institute for Developmental Disabilities — Recruiting
Tennessee
Nashville (1)
- Monroe Carell Jr. Children's Hospital at Vanderbilt — Recruiting
Contact information
- Wen-Hann Tan, BMBS
617-355 6394
wen-hann.tan@childrens.harvard.edu - Batsheva Friedman, MA
617-355-2030
Batsheva.Friedman@childrens.harvard.edu
Full registry eligibility criteria
Inclusion Criteria: * Molecular diagnosis of Angelman syndrome Exclusion Criteria: * Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
Important information
Registry information may change. FAST context and classifications are editorial additions. Inclusion does not confirm eligibility or availability at a specific site. Review the official record and contact the study team for participation requirements.